Template:21-hydroxylase deficiency: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) m (Usama Talib moved page Template:21-Hydroxylase Deficiency to Template:21-hydroxylase deficiency without leaving a redirect) |
Usama Talib (talk | contribs) No edit summary |
||
Line 10: | Line 10: | ||
|- bgcolor="LightCoral" | |- bgcolor="LightCoral" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency|Home]] | ||
|- | |- | ||
! | ! | ||
Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
Line 22: | Line 22: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency overview|Overview]] | ||
|- | |- | ||
! | ! | ||
Line 28: | Line 28: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency historical perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
Line 34: | Line 34: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency classification|Classification]] | ||
|- | |- | ||
! | ! | ||
Line 40: | Line 40: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
Line 46: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency causes|Causes]] | ||
|- | |- | ||
! | ! | ||
Line 52: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency differential diagnosis|Differentiating 21-Hydroxylase Deficiency from other Diseases]] | ||
|- | |- | ||
! | ! | ||
Line 58: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 64: | Line 64: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 70: | Line 70: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 76: | Line 76: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! |
Revision as of 19:48, 19 July 2017
21-Hydroxylase Deficiency Microchapters |
Differentiating 21-Hydroxylase Deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency |
Risk calculators and risk factors for 21-hydroxylase deficiency |